The Effect of Motivational Interviewing and Education Based on Watson's Theory of Human Caring in Hemodialysis
CompletedNAResults postedLast updated 23 February 2021
What this trial tests
NA trial testing Motivational Interviewing and Education Based on Watson's Theory of Human Caring in Renal Disease in 60 participants. Completed in 17 June 2020.
Timeline
1 April 2019
Primary endpoint 1 April 2020
17 June 2020
Quick facts
Lead sponsor
Akdeniz University
Phase
NA
Status
Completed
Study type
INTERVENTIONAL
Allocation
randomized
Design
parallel
Masking
single
Primary purpose
supportive care
Enrollment
60
Start date
1 April 2019
Primary completion
1 April 2020
Estimated completion
17 June 2020
Sites
1 location across Turkey (Türkiye)
Drugs / interventions tested
Motivational Interviewing and Education Based on Watson's Theory of Human Caring
18 and older, any sex, with Renal Disease or Adherence, Treatment. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Change From Baseline in Adherence to Fluid Intake on the Fluid Control in Hemodialysis Patients Scale at Week 12Primary· baseline and 12 week
This scale measure adherence to fluid intake.The scale had 24 items and 3 point likert scale. It was included three sub-dimensions: knowledge, behaviors, and attitudes. The knowledge sub-dimension included 7 items and it's score ranged from 7-21. A high score indicates that individuals have higher levels of knowledge about fluid intake. The behavior sub-dimension included 11 items and it's score ranged from 11-33. A high score indicates that individuals' behavior is positive in adherence to fluid intake. The attitudes sub-dimension included 6 items and it's score ranged from 6-18. A high score
Knowledge sub-scale
Group
Value
95% CI
Intervention Group
1.37
± 3.54
Control Group
-0.17
± 1.44
Behaviour sub-scale
Group
Value
95% CI
Intervention Group
3.31
± 4.23
Control Group
0.50
± 3.92
Attitude sub-scale
Group
Value
95% CI
Intervention Group
6.46
± 1.86
Control Group
2.21
± 2.52
Total score
Group
Value
95% CI
Intervention Group
11.15
± 5.26
Control Group
2.53
± 4.72
Change From Baseline in Adherence to Diet on the Scale for Dietary Behaviors in Hemodialysis Patients at Week 12Primary· Baseline and 12 week
Scale for Dietary Behaviors in Hemodialysis Patients: This scale evaluate adherence to diet management in hemodialysis patients. The scale had 13 items and 5 point likert scale. The score ranged from 13-65. High score indicates that adherence to diet management is high. The scale was developed in Turkey.The change between week 12 score and baseline score was reported.
Group
Value
95% CI
Intervention Group
7.62
± 5.51
Control Group
3.10
± 4.99
Change From Baseline in Adherence to Drug Management on the Modified Morisky Scale at Week 12Primary· Baseline and 12 week
Modified Morisky Scale: This scale evaluate adherence to drug management. It is consist of six items and two sub-dimensions:knowledge and motivation. The lowest and highest score is between 0-3 for each sub-dimension. A score higher than zero each sub-dimension indicates high knowledge and motivation in the adherence to drug management. The change between week 12 score and baseline score was reported
Knowledge sub-dimension
Group
Value
95% CI
Intervention Group
1.00
± 0.67
Control Group
0.46
± 0.50
Motivation sub-dimension
Group
Value
95% CI
Intervention Group
0.68
± 0.47
Control Group
0.71
± 0.26
The Mean of Satisfaction of the Intervention Group From the Introduced Intervention Based on Theory Using Watson Caritas Patient Score at Week 12Primary· 12 week
Watson Caritas Patient Score: This questionnaire evaluate the satisfaction with nursing care based on Watson's Theory of Human Caring. It is a likert-type form consist of five items. The score of each item ranged from 1-7. As the mean score from each item approaches 7, it shows that individuals are satisfied with care. This questionnaire will perform only to the intervention group. The mean score of the each item of the questionnaire was reported. The data were not collected for this Outcome Measure from participants in the "Control Group" Arm/Group.
Deliver my care with loving-kindness
Group
Value
95% CI
Intervention Group
6.40
± 0.49
Meet my basic human needs.
Group
Value
95% CI
Intervention Group
6.43
± 0.66
Have helping and trusting relationships with me.
Group
Value
95% CI
Intervention Group
6.34
± 0.70
Create a caring environment that helps me to heal.
Group
Value
95% CI
Intervention Group
6.25
± 0.67
Value my personal beliefs and faith, allowing for
Group
Value
95% CI
Intervention Group
6.37
± 0.65
The Mean of Satisfaction From the Motivational Interviewing Evaluated With Motivational Interview Evaluation Form at Week 12Primary· 12 week
Motivational Interview Evaluation Form: This form was used to evaluated the satisfaction with motivational interviewing and it was prepared by the researcher. This form consists of a item that includes evaluating the motivational interviewing satisfaction with likert scale and two items that include evaluating the inadequacies of the interviewing with open-ended question. The total mean score ranged from 1-5. As the mean score from first item approaches 5, it shows that individuals are satisfied with motivational interviewing.This form will perform only to the intervention group. The mean of t
Group
Value
95% CI
Intervention Group
4.5
± 0.5
Change From Baseline in Quality of Life on the Kidney Disease Quality of Life Instrument 36 Scale at Week 12Primary· baseline and 12 week
Kidney Disease Quality of Life Instrument 36 ıtem:This instrument evaluate quality of life of individuals with chronic kidney disease. The KDQOL-36 consists of 36 items and five sub-dimensions: physical and mental functions, kidney disease burden, symptoms and problems, effects of kidney disease on daily life. The scoring of the each sub-scale ranges from 0 to 100. A higher score in each sub-dimension is an indicator of better health and quality of life. The change between week 12 score and baseline score was reported.
Physical functions sub-dimension
Group
Value
95% CI
Intervention Group
3.83
± 9.33
Control Group
2.36
± 6.82
Mental functions sub-dimension
Group
Value
95% CI
Intervention Group
6.60
± 9.52
Control Group
3.50
± 7.92
Burden of kidney disease sub-dimension
Group
Value
95% CI
Intervention Group
14.06
± 22.33
Control Group
4.68
± 9.56
Symptoms/problems sub-dimension
Group
Value
95% CI
Intervention Group
11.45
± 9.96
Control Group
10.49
± 11.31
Effects of kidney disease on daily life sub-dimension
Group
Value
95% CI
Intervention Group
18.74
± 15.30
Control Group
13.72
± 8.12
Sponsor's own description
* Motivational interviewing and education based on Watson's Theory of Human Caring have an effect on increasing adherence to fluid intake in individuals receiving hemodialysis treatment.
* Motivational interviewing and education based on Watson's Theory of Human Caring have an effect on increasing adherence to diet in individuals receiving hemodialysis treatment.
* Motivational interviewing and education based on Watson's Theory of Human Caring have an effect on increasing adherence to drug management in individuals receiving hemodialysis treatment.
* Intervention group who receiving Motivational interviewing and education based on Watson's Theory of Human Caring would satisfied with introduced intervention.
* Motivational interviewing and education based on Watson's Theory of Human Caring have an effect on increasing quality of life in individuals receiving hemodialysis treatment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Akdeniz University
Last refreshed: 23 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04174638.